Zobrazeno 1 - 10
of 22
pro vyhledávání: '"F. M. Foss"'
Autor:
S. P. Iyer, R. A. Sica, P. J. Ho, B. Hu, J. Zain, A. Prica, W.-K. Weng, Y. H. Kim, M. S. Khodadoust, M. L Palomba, F. M. Foss, K. Tipton, E. L. Cullingford, Q. He, A. Sharma, S. M. Horwitz
Publikováno v:
HemaSphere, Vol 6, Pp 163-164 (2022)
Externí odkaz:
https://doaj.org/article/58dc7ef513b2466ca7b98689ed5f90a1
Autor:
F M, Foss
Publikováno v:
Clinical lymphoma. 1
Genetic engineering has led to the development of fusion protein toxins, which are targeted effector molecules that combine a targeting ligand such as a growth factor with a cytocidal moiety such as a plant or bacterial toxin. The first genetically c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8762878c7d08b691730a3a2c96a3e1bb
https://pubmed.ncbi.nlm.nih.gov/11707860
https://pubmed.ncbi.nlm.nih.gov/11707860
Autor:
F M, Foss
Publikováno v:
Oncology (Williston Park, N.Y.). 14(6 Suppl 2)
Pentostatin (Nipent) has demonstrated significant activity as a single agent in patients with low-grade B- and T-cell lymphomas, but thus far, clinical experience with combinations of pentostatin and other agents is limited. A study of alternating ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f6fa51d30db3f4cf051d90e6a018b8ee
https://pubmed.ncbi.nlm.nih.gov/10887642
https://pubmed.ncbi.nlm.nih.gov/10887642
Autor:
F M, Foss
Publikováno v:
Seminars in oncology. 27(2 Suppl 5)
Cutaneous T-cell lymphoma (CTCL) comprises a constellation of diseases of malignant clonal T lymphocytes that present initially in the skin. Since biochemical studies of pentostatin suggested that T cells are more sensitive to the effects of inhibiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::599da551fcea98813ed78f89742ce3ff
https://pubmed.ncbi.nlm.nih.gov/10877054
https://pubmed.ncbi.nlm.nih.gov/10877054
Publikováno v:
Cancer. 86(7)
This Phase II study was undertaken to assess the efficacy and toxicity of chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone (EPOCH regimen) in patients with advanced, refractory cutaneous T-cell lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e37f507941e25c948145447db8d025b5
https://pubmed.ncbi.nlm.nih.gov/10506727
https://pubmed.ncbi.nlm.nih.gov/10506727
Autor:
F M, Foss, T M, Kuzel
Publikováno v:
Cancer treatment and research. 99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::806c6a630d0770fd7efd848672622177
https://pubmed.ncbi.nlm.nih.gov/9891869
https://pubmed.ncbi.nlm.nih.gov/9891869
Autor:
F M, Foss, A, Raubitscheck, J L, Mulshine, T A, Fleisher, J C, Reynolds, C H, Paik, R D, Neumann, C, Boland, P, Perentesis, M R, Brown, J M, Frincke, C P, Lollo, S M, Larson, J A, Carrasquillo
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(11)
Ten patients with advanced or refractory CD5-expressing hematologic neoplasms [two with chronic lymphocytic leukemia and eight with cutaneous T-cell lymphoma (CTCL)] were treated in a Phase I study with the radioimmunoconjugate 90Y-T101, which target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::991b3cc0ea96fba266947e9bdd754eba
https://pubmed.ncbi.nlm.nih.gov/9829731
https://pubmed.ncbi.nlm.nih.gov/9829731
Publikováno v:
Oncology (Williston Park, N.Y.). 12(10)
Cutaneous lymphomas comprise a spectrum of diseases characterized by infiltration of the skin by malignant lymphocytes. The clinical manifestations of cutaneous lymphomas vary, and they can mimic benign dermatoses, as well as nodal or visceral malign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c2c16ad11c7075ed5ebceb27ea0b5f5
https://pubmed.ncbi.nlm.nih.gov/9798206
https://pubmed.ncbi.nlm.nih.gov/9798206
Publikováno v:
Current topics in microbiology and immunology. 234
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8d9fa7302380d4beedc3cd4b8b0896cd
https://pubmed.ncbi.nlm.nih.gov/9670613
https://pubmed.ncbi.nlm.nih.gov/9670613
Publikováno v:
Journal of the American Academy of Dermatology. 36(3 Pt 1)
At the International Consensus Conference for Cutaneous T-Cell Lymphoma (CTCL) Treatment Recommendations (held in Boston, Massachusetts, Oct. 1 and 2, 1994), international experts were asked to assess where consensus existed and to identify areas tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4d1298428ae1378d1472783871071fd
https://pubmed.ncbi.nlm.nih.gov/9486695
https://pubmed.ncbi.nlm.nih.gov/9486695